A Split‐Face Micro‐Needling Study to Evaluate the Efficacy and Consumer Perception of a Novel Moisturization Agent

Aestura ATOBARRIER 365 Cream with ceramides demonstrated efficacy in improving skin barrier recovery, reducing TEWL, and enhancing skin texture following microneedling. The significant reductions in TEWL, erythema, and roughness highlight its ability to restore the skin's barrier, calm irritation, and refine texture. These findings confirm its role in supporting skin recovery and resilience after dermatological treatments, making it a valuable addition to post-procedure care. While these results support its effectiveness in post-procedural recovery, further research is needed to determine its applicability for other conditions involving compromised skin barriers, such as eczema or rosacea. Additional studies are also warranted to assess long-term efficacy and its potential role in optimizing skin barrier restoration across diverse patient populations.